These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 36401256)

  • 21. Evaluation of a novel screening method for fetal aneuploidy using cell-free DNA in maternal plasma.
    Porreco RP; Sekedat M; Bombard A; Garite TJ; Maurel K; Marusiak B; Adair D; Bleich A; Combs CA; Kramer W; Longo S; Nageotte M; Samuel A; Vanderhoeven J; Buis J; Jacobs KB; Stoerker J
    J Med Screen; 2020 Mar; 27(1):1-8. PubMed ID: 31510865
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-invasive prediction of fetal growth restriction by whole-genome promoter profiling of maternal plasma DNA: a nested case-control study.
    Xu C; Guo Z; Zhang J; Lu Q; Tian Q; Liu S; Li K; Wang K; Tao Z; Li C; Lv Z; Zhang Z; Yang X; Yang F
    BJOG; 2021 Jan; 128(2):458-466. PubMed ID: 32364311
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cell-free fetal DNA in amniotic fluid: unique fragmentation signatures in euploid and aneuploid fetuses.
    Lapaire O; Bianchi DW; Peter I; O'Brien B; Stroh H; Cowan JM; Tantravahi U; Johnson KL
    Clin Chem; 2007 Mar; 53(3):405-11. PubMed ID: 17259241
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Screening of fetal chromosomal aneuploidy diseases using noninvasive prenatal testing in twin pregnancies.
    Yu W; Lv Y; Yin S; Liu H; Li X; Liang B; Kong L; Liu C
    Expert Rev Mol Diagn; 2019 Feb; 19(2):189-196. PubMed ID: 30582381
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Practice of clinical application of noninvasive prenatal testing based on cell-free fetal DNA].
    Duan H; Wang W; Zhang Y; Liu W; Gu L; Li J
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2022 Mar; 39(3):264-268. PubMed ID: 35315033
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of cell-free DNA in a consecutive series of 13,607 routine cases for the detection of fetal chromosomal aneuploidies in a single center in Germany.
    Borth H; Teubert A; Glaubitz R; Knippenberg S; Kutur N; Winkler T; Eiben B
    Arch Gynecol Obstet; 2021 Jun; 303(6):1407-1414. PubMed ID: 33151425
    [TBL] [Abstract][Full Text] [Related]  

  • 27. First-trimester risk assessment based on ultrasound and cell-free DNA vs combined screening: a randomized controlled trial.
    Kagan KO; Sroka F; Sonek J; Abele H; Lüthgens K; Schmid M; Wagner P; Brucker S; Wallwiener D; Hoopmann M
    Ultrasound Obstet Gynecol; 2018 Apr; 51(4):437-444. PubMed ID: 28925570
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Usefulness and reliability of cell free fetal DNA screening for main trisomies in case of atypical profile on first trimester maternal serum screening.
    Carrara J; Vivanti A; Jani JC; Demain A; Costa JM; Benachi A
    J Transl Med; 2019 Nov; 17(1):398. PubMed ID: 31779618
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fetal aneuploidy screening by non-invasive prenatal testing of maternal plasma DNA sequencing with "false negative" result due to confined placental mosaicism: A case report.
    Li X; Ju D; Shi Y; Li Y; Dong H; Huang J; Zhang Y
    Medicine (Baltimore); 2020 Jul; 99(29):e20848. PubMed ID: 32702826
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma.
    Chiu RW; Chan KC; Gao Y; Lau VY; Zheng W; Leung TY; Foo CH; Xie B; Tsui NB; Lun FM; Zee BC; Lau TK; Cantor CR; Lo YM
    Proc Natl Acad Sci U S A; 2008 Dec; 105(51):20458-63. PubMed ID: 19073917
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aneuploidy screening by non-invasive prenatal testing in twin pregnancy.
    Fosler L; Winters P; Jones KW; Curnow KJ; Sehnert AJ; Bhatt S; Platt LD
    Ultrasound Obstet Gynecol; 2017 Apr; 49(4):470-477. PubMed ID: 27194226
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Routine first-trimester screening for fetal trisomies in twin pregnancy: cell-free DNA test contingent on results from combined test.
    Galeva S; Konstantinidou L; Gil MM; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2019 Feb; 53(2):208-213. PubMed ID: 30353581
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Universal Cell Free DNA or Contingent Screening for Trisomy 21: Does It Make a Difference? A Comparative Study with Real Data.
    Prodan NC; Wiechers C; Geipel A; Walter A; Siegmann HJ; Kozlowski P; Hoopmann M; Kagan KO
    Fetal Diagn Ther; 2022; 49(3):85-94. PubMed ID: 35339997
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical Practice Guidelines for Prenatal Aneuploidy Screening and Diagnostic Testing from Korean Society of Maternal-Fetal Medicine: (1) Prenatal Aneuploidy Screening.
    Choe SA; Seol HJ; Kwon JY; Park CW; Kim M; Lee JY; Kim MA; Hwang HS; Na S; Shim JY; Kim K; Ryu HM
    J Korean Med Sci; 2021 Jan; 36(4):e27. PubMed ID: 33496086
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A dPCR-NIPT assay for detections of trisomies 21, 18 and 13 in a single-tube reaction-could it replace serum biochemical tests as a primary maternal plasma screening tool?
    Dai P; Yang Y; Zhao G; Gu Z; Ren H; Hu S; Liu N; Jiao W; Li J; Kong X
    J Transl Med; 2022 Jun; 20(1):269. PubMed ID: 35706031
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Noninvasive prenatal detection of fetal trisomy 18 by epigenetic allelic ratio analysis in maternal plasma: Theoretical and empirical considerations.
    Tong YK; Ding C; Chiu RW; Gerovassili A; Chim SS; Leung TY; Leung TN; Lau TK; Nicolaides KH; Lo YM
    Clin Chem; 2006 Dec; 52(12):2194-202. PubMed ID: 17040955
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Non-invasive prenatal testing for fetal chromosomal abnormalities by low-coverage whole-genome sequencing of maternal plasma DNA: review of 1982 consecutive cases in a single center.
    Lau TK; Cheung SW; Lo PS; Pursley AN; Chan MK; Jiang F; Zhang H; Wang W; Jong LF; Yuen OK; Chan HY; Chan WS; Choy KW
    Ultrasound Obstet Gynecol; 2014 Mar; 43(3):254-64. PubMed ID: 24339153
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Maternal plasma genome-wide cell-free DNA can detect fetal aneuploidy in early and recurrent pregnancy loss and can be used to direct further workup.
    Yaron Y; Pauta M; Badenas C; Soler A; Borobio V; Illanes C; Paz-Y-Miño F; Martinez-Portilla R; Borrell A
    Hum Reprod; 2020 May; 35(5):1222-1229. PubMed ID: 32386059
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fetal DNA in maternal plasma is elevated in pregnancies with aneuploid fetuses.
    Zhong XY; Bürk MR; Troeger C; Jackson LR; Holzgreve W; Hahn S
    Prenat Diagn; 2000 Oct; 20(10):795-8. PubMed ID: 11038456
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Whole genome non-invasive prenatal testing in prenatal screening algorithm: clinical experience from 12,700 pregnancies.
    Baranova EE; Sagaydak OV; Galaktionova AM; Kuznetsova ES; Kaplanova MT; Makarova MV; Belenikin MS; Olenev AS; Songolova EN
    BMC Pregnancy Childbirth; 2022 Aug; 22(1):633. PubMed ID: 35945516
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.